loadpatents
Patent applications and USPTO patent grants for BOND; Silas.The latest application filed is for "compounds for and methods of treating diseases".
Patent | Date |
---|---|
Compounds For And Methods Of Treating Diseases App 20220064142 - BOND; Silas ;   et al. | 2022-03-03 |
Compounds for and methods of treating diseases Grant 11,155,547 - Bond , et al. October 26, 2 | 2021-10-26 |
Imidazo [1,5-a]pyridine compounds and their use Grant 10,941,143 - Bond , et al. March 9, 2 | 2021-03-09 |
Compounds For And Methods Of Treating Diseases App 20200291021 - BOND; Silas ;   et al. | 2020-09-17 |
Polycyclic agents for the treatment of respiratory syncytial virus infections Grant 9,675,694 - Mitchell , et al. June 13, 2 | 2017-06-13 |
Viral polymerase inhibitors Grant 9,447,080 - Jeynes , et al. September 20, 2 | 2016-09-20 |
Viral polymerase inhibitors Grant 9,365,554 - Bond , et al. June 14, 2 | 2016-06-14 |
Viral polymerase inhibitors Grant 9,120,775 - Jeynes , et al. September 1, 2 | 2015-09-01 |
Viral Polymerase Inhibitors App 20150175592 - Bond; Silas ;   et al. | 2015-06-25 |
Viral Polymerase Inhibitors App 20150065445 - Jeynes; Tyrone Pieter ;   et al. | 2015-03-05 |
Bicyclic nucleosides and nucleotides as therapeutic agents Grant 8,802,840 - Francom , et al. August 12, 2 | 2014-08-12 |
Viral polymerase inhibitors Grant 8,785,478 - Bond , et al. July 22, 2 | 2014-07-22 |
Polycyclic Agents for the Treatment of Respiratory Syncytial Virus Infections App 20140051689 - Bond; Silas ;   et al. | 2014-02-20 |
Polycyclic Agents For The Treatment Of Respiratory Syncytial Virus Infections App 20140004111 - Mitchell; Jeffrey Peter ;   et al. | 2014-01-02 |
Polycyclic agents for the treatment of respiratory syncytial virus infections Grant 8,598,194 - Mitchell , et al. December 3, 2 | 2013-12-03 |
Polycyclic agents for the treatment of respiratory syncytial virus infections Grant 8,598,193 - Bond , et al. December 3, 2 | 2013-12-03 |
Viral Polymerase Inhibitors App 20130274218 - Jeynes; Tyrone Pieter ;   et al. | 2013-10-17 |
Viral Polymerase Inhibitors App 20130274179 - Bond; Silas ;   et al. | 2013-10-17 |
Bicyclic nucleosides and nucleotides as therapeutic agents Grant 8,501,699 - Francom , et al. August 6, 2 | 2013-08-06 |
Bicyclic Nucleosides And Nucleotides As Therapeutic Agents App 20130018013 - Francom; Paula ;   et al. | 2013-01-17 |
Bicyclic Nucleosides And Nucleotides As Therapeutic Agents App 20120122811 - Francom; Paula ;   et al. | 2012-05-17 |
Bicyclic nucleosides and nucleotides as therapeutic agents Grant 8,119,607 - Francom , et al. February 21, 2 | 2012-02-21 |
Bicyclic Nucleosides And Nucleotides As Therapeutic Agents App 20100291031 - Francom; Paula ;   et al. | 2010-11-18 |
Bicyclic Nucleosides And Nucleotides As Therapeutic Agents App 20100035836 - Francom; Paula ;   et al. | 2010-02-11 |
Polycyclic Agents For The Treatment Of Respiratory Syncytial Virus Infections App 20100021458 - Mitchell; Jeffrey Peter ;   et al. | 2010-01-28 |
Bicyclic Nucleosides and Nucleotides as Therapeutic Agents App 20090004138 - Francom; Paula ;   et al. | 2009-01-01 |
Polycyclic agents for the treatment of respiratory syncytial virus infections App 20070287700 - Bond; Silas ;   et al. | 2007-12-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.